Institutional asset management firms, large mutual fund complexes, and specialized international investment trusts hold the vast majority of Novartis AG shares. Prominent institutional stakeholders filing regular regulatory disclosures include major global financial entities such as Fisher Asset Management, Dodge & Cox, Dimensional Fund Advisors, and Vanguard affiliates, alongside various international exchange-traded funds and pension accounts that maintain significant equity blocks.